Dinner Talk: Venture Investing Enabled by AI


Location: Friend Center, 006

Speaker: David Coats '87

Portrait of David Coats

The Keller Center is pleased to welcome David Coats '87, Founder and Managing Director of Correlation Ventures, to the Princeton campus on Thursday, March 28. Coats will discuss the unique way in which his firm approaches investing, and in particular, the use of analytic software to optimize decisions. Dinner will be provided.

NOTE: this event is open to Princeton University undergrad and grad students, faculty, and postdocs. Seating is very limited and registration is required.  


David Coats Bio

As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital.

David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.

David received an M.B.A. from the Harvard Graduate School of Business Administration and graduated Summa Cum Laude with a B.S. in Biology from Princeton University.